Innovative formulation of nystatin particulate systems in toothpaste for candidiasis treatment

被引:33
作者
Reis, Catarina Pinto [1 ]
Roque, Luis Vasques [2 ]
Baptista, Marina [1 ]
Rijo, Patricia [1 ]
机构
[1] Univ Lusofona Humanidades & Tecnol, CBIOS Res Ctr Biosci & Hlth Technol, Campo Grande 376, P-1749024 Lisbon, Portugal
[2] Univ Lusofona Humanidades & Tecnol, Sch Sci & Hlth Technol ECTS, P-1749024 Lisbon, Portugal
关键词
Candida albicans; encapsulation; nystatin; oral drug delivery; IN-VITRO; ANTIFUNGAL ACTIVITY; LIPOSOMAL NYSTATIN; AMPHOTERICIN-B; ORAL DELIVERY; ALBICANS; NANOPARTICLES; MICROSPHERES; FLUCONAZOLE; SALIVA;
D O I
10.3109/10837450.2014.999783
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Oral candidiasis is a mycosis on the mucous membranes of the mouth but not limited to the mouth. Nystatin is one of the most frequently employed antifungal agents to treat infections and may be safely given orally as well as applied topically but its absorption through mucocutaneous membranes such as the gut and the skin is minimal. The purpose of this study is to enhance the effectiveness of nystatin using particulate system such as beads, micro- and nanoparticles of alginate incorporated into toothpaste. Those particulate systems of nystatin were prepared by extrusion/external gelation for beads and emulsification/internal gelation for micro- and nanoparticles and characterized. Small, anionic charged and monodispersed particles were successfully produced. The type of particulate system influenced all previous parameters, being microparticles the most suitable particulate system of nystatin showing the slowest release, the highest inhibitory effect of Candida albicans over a period of one year. Those results allowed the conclusion that alginate exhibits properties that enable the in vitro functionality of encapsulated nystatin and thus may provide the basis for new successful approaches for the treatment of oral antifungal infections such as oral candidiasis.
引用
收藏
页码:282 / 287
页数:6
相关论文
共 51 条
[1]   Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics [J].
Allémann, E ;
Leroux, JC ;
Gurny, R .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 34 (2-3) :171-189
[2]   Microdilution antifungal susceptibility testing of Candida albicans and Cryptococcus neoformans with and without agitation: An eight-center collaborative study [J].
Anaissie, EJ ;
Paetznick, VL ;
Ensign, LG ;
EspinelIngroff, A ;
Galgiani, JN ;
Hitchcock, CA ;
LaRocco, M ;
Patterson, T ;
Pfaller, MA ;
Rex, JH ;
Rinaldi, MG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (10) :2387-2391
[3]   Determination of minimum inhibitory concentrations [J].
Andrews, JM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 :5-16
[4]   Polymeric carriers for oral uptake of microparticulates [J].
Andrianov, AK ;
Payne, LG .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 34 (2-3) :155-170
[5]   In vitro activity of nystatin compared with those of liposomal nystatin, amphotericin B, and fluconazole against clinical Candida isolates [J].
Arikan, S ;
Ostrosky-Zeichner, L ;
Lozano-Chiu, M ;
Paetznick, V ;
Gordon, D ;
Wallace, T ;
Rex, JH .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (04) :1406-1412
[6]   A NOVEL-APPROACH TO THE ORAL DELIVERY OF MICRO-PARTICLES OR NANOPARTICLES [J].
BODMEIER, R ;
CHEN, HG ;
PAERATAKUL, O .
PHARMACEUTICAL RESEARCH, 1989, 6 (05) :413-417
[7]   The influence of artificial body fluids on metallic corrosion [J].
Brett, CMA ;
Muresan, I .
ADVANCED MATERIALS FORUM I, 2002, 230-2 :459-462
[8]   EFFECT OF FLAVOR AND DETERGENT ON FLUORIDE AVAILABILITY IN WHOLE SALIVA AFTER USE OF NAF AND MFP DENTIFRICES [J].
BRUUN, C ;
QVIST, V ;
THYLSTRUP, A .
CARIES RESEARCH, 1987, 21 (05) :427-434
[9]  
CLSI, 2008, REF METH BROTH DIL A, V28
[10]   Cooperative partition model of nystatin interaction with phospholipid vesicles [J].
Coutinho, A ;
Prieto, M .
BIOPHYSICAL JOURNAL, 2003, 84 (05) :3061-3078